Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gateways to clinical trials.

M Bayes1, X Rabasseda, J R Prous

  • 1Prous Science, Barcelona, Spain. mbayes@prous.com

Methods and Findings in Experimental and Clinical Pharmacology
|July 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A report from the World Conference on Lung Cancer (September 6-9, 2015 - Denver, Colorado, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the American Association of Urology Annual Meeting 2015 (May 15-19 - New Orleans, Louisiana, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 73rd Annual Meeting of the American Academy of Dermatology (March 20-24 - San Francisco, California, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the European Association for the Study of the Liver's 50th International Liver Congress (April 22-26 - Vienna, Austria).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26--Seattle, Washington, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 2014 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting (November 14-19 - Boston, Massachusetts, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same journal

[Proceedings of the XVIII TASPE Seminar, Granada, Spain, 4-5 February 2010].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment algorithm for gastrointestinal graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Classification of chronic graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Pegfilgrastim in hematopoietic stem cell transplantation].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010].

Methods and findings in experimental and clinical pharmacology·2011
See all related articles

This resource provides a comprehensive overview of recent clinical trials across various therapeutic areas. It highlights emerging drug candidates and therapies, aiding researchers in tracking advancements in drug discovery and development.

Area of Science:

  • Drug Discovery and Development
  • Clinical Trials
  • Pharmaceutical Research

Context:

  • Prous Science Integrity portal provides data on current clinical trials.
  • This issue focuses on a wide selection of drugs and therapies.
  • Information is sourced from literature and congresses.

Purpose:

  • To guide researchers and clinicians to the latest clinical trial information.
  • To offer a snapshot of ongoing drug development.
  • To facilitate access to emerging therapeutic data.

Summary:

  • The guide details numerous drugs including 131-I-chlorotoxin, adalimumab, alemtuzumab, and Bevacizumab.
  • It covers a broad spectrum of therapeutic agents such as gefitinib, imatinib mesylate, and vorinostat.

Related Experiment Videos

  • The compilation includes vaccines and novel drug delivery systems.

    • Impact:

    • Facilitates the identification of potential collaborators and research opportunities.
    • Supports evidence-based decision-making in pharmaceutical R&D.
    • Accelerates the understanding of new treatment modalities.